EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer

Sherly I Celada, Guoliang Li, Lindsay J Celada, Wenfu Lu, Thanigaivelan Kanagasabai, Weiran Feng, Zhen Cao, Nazifa Salsabeel, Ninghui Mao, LaKendria K Brown, Zaniya A Mark, Michael G Izban und 6 weitere

Molecular Oncology · 2023

DOI: 10.1002/1878-0261.13497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2023. Verfasst von Sherly I Celada und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIMHD NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Changes in FOXA1 (forkhead box protein A1) protein levels are well associated with prostate cancer (PCa) progression. Unfortunately, direct targeting of FOXA1 in progressive PCa remains challenging due to variations in FOXA1 protein levels, increased FOXA1 mutations at different stages of PCa, and elusive post‐translational FOXA1 regulating mechanisms. Here, we show that SKP2 (S‐phase kinase‐associated protein 2) catalyzes K6‐ and K29‐linked polyubiquitination of FOXA1 for lysosomal‐dependent degradation. Our data indicate increased SKP2:FOXA1 protein ratios in stage IV human PCa compared to stages I–III, together with a strong inverse correlation ( r = −0.9659) between SKP2 and FOXA1 levels, suggesting that SKP2–FOXA1 protein interactions play a significant role in PCa progression. Prostate tumors of Pten/Trp53 mice displayed increased Skp2–Foxa1–Pcna signaling and colocalization, whereas disruption of the Skp2–Foxa1 interplay in Pten/Trp53/Skp2 triple‐null mice demonstrated decreased Pcna levels and increased expression of Foxa1 and luminal positive cells. Treatment of xenograft mice with the SKP2 inhibitor SZL P1‐41 decreased tumor proliferation, SKP2:FOXA1 ratios, and colocalization. Thus, our results highlight the significance of the SKP2–FOXA1 interplay on the luminal lineage in PCa and the potential of therapeutically targeting FOXA1 through SKP2 to improve PCa control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAnimalsHumansMaleMiceHepatocyte Nuclear Factor 3-alphaLysosomesMice, KnockoutProliferating Cell Nuclear AntigenUbiquitination

Stichwörter der Autor:innen

FOXA1SKP2luminal lineageprostate cancerubiquitination

Substanzen

FOXA1 protein, humanHepatocyte Nuclear Factor 3-alphaProliferating Cell Nuclear AntigenFoxa1 protein, mouse

Autor:innen und Institutionen

  • Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN, USA.
  • Department of Biological Sciences, Tennessee State University, Nashville, TN, USA.
  • Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA.
  • Department of Pathology, Anatomy and Cell Biology, Meharry Medical College, Nashville, TN, USA.

ORCID-Profile: Zhenbang Chen

Förderung

  • NCATS NIH HHS
  • NIMHD NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • American Cancer Society
  • National Institutes of Health
  • U.S. Department of Defense

Zitieren

APA

Celada, S. I., Li, G., Celada, L. J., Lu, W., Kanagasabai, T., Feng, W., Cao, Z., Salsabeel, N., Mao, N., Brown, L. K., Mark, Z. A., Izban, M. G., Ballard, B. R., Zhou, X., Adunyah, S. E., Matusik, R. J., Wang, X., & Chen, Z. (2023). Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer. Molecular Oncology. https://doi.org/10.1002/1878-0261.13497

Vancouver

Celada SI, Li G, Celada LJ, Lu W, Kanagasabai T, Feng W, et al. Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer. Molecular Oncology. 2023. doi:10.1002/1878-0261.13497

BibTeX
@article{Celada2023,
  author = {Celada, Sherly I and Li, Guoliang and Celada, Lindsay J and Lu, Wenfu and Kanagasabai, Thanigaivelan and Feng, Weiran and Cao, Zhen and Salsabeel, Nazifa and Mao, Ninghui and Brown, LaKendria K and Mark, Zaniya A and Izban, Michael G and Ballard, Billy R and Zhou, Xinchun and Adunyah, Samuel E and Matusik, Robert J and Wang, Xiaofei and Chen, Zhenbang},
  title = {Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer},
  journal = {Molecular Oncology},
  year = {2023},
  doi = {10.1002/1878-0261.13497}
}
Kostenlos starten →